Study Exploring the Supportive Effect of Acarbose in Weight Management
Status:
ACTIVE_NOT_RECRUITING
Trial end date:
2024-03-15
Target enrollment:
Participant gender:
Summary
This is a randomized, double-blind study in participants with overweight or obesity in which the effect of acarbose and the impact of dose on efficacy, safety and tolerability is investigated by comparing the EMP16 combination product with modified release (MR) orlistat, orlistat in its conventional dosage form and placebo.